This review highlights the recent evidence describing the outcomes associated with fluid overload in critically ill patients and provides an overview of fluid management strategies aimed at preventing fluid overload during the resuscitation of patients with shock.
INTRODUCTION
Fluid overload is a relatively frequent occurrence in critically ill patients and is often a consequence of critical care intervention. Despite a common perception that it is benign, fluid overload in the critically ill is independently associated with increased morbidity and mortality. Thus, intravenous fluids need to be dosed appropriately to reduce the risk of harm associated with this potentially life-saving therapy. This review presents the recent evidence relevant to fluid overload in critically ill patients and provides an overview of fluid management strategies aimed at preventing fluid overload during the resuscitation of patients presenting with shock.
OUTCOMES ASSOCIATED WITH FLUID OVERLOAD
Fluid extravasation into the interstitial space can adversely affect multiple organ systems (Table 1) . Although characterizing fluid overload in every organ system is difficult (that is some systems lend themselves to fluid measurement and correlation with function more than others), increasing evidence has been noted in the pulmonary, cardiac, renal and gastrointestinal systems. Graded increases in extravascular lung water impair oxygenation and are independently associated with mortality [1] . Increased renal interstitial fluid may reduce capillary blood flow and lead to renal ischemia, which can cause or worsen acute kidney injury (AKI). Fluid overload can also worsen myocardial and liver function, impair coagulation, delay wound healing and is a risk factor for intra-abdominal hypertension [2] . In the gastrointestinal system, diffuse intestinal wall edema can cause malabsorption and ileus. Other organ systems, such as the neurologic system, are more difficult to assess for fluid overload and associated complications.
The effect of tissue edema on organ function likely contributes to the association between fluid overload and increased morbidity and mortality. This association has been demonstrated in multiple studies involving patients with severe sepsis and the acute respiratory distress syndrome (ARDS) [ ] analyzed data from a prospectively collected registry of 492 ICU patients with AKI who received more than 2 days of renal replacement therapy. The study identified that a higher mean daily fluid balance independently increased the odds of hospital mortality [ ]. Patients with fluid overload also had a twofold longer ICU stay, 4% higher hospital mortality and 0.5% higher risk for 30-day readmissions.
HOW TO PREVENT FLUID OVERLOAD
Fluid management strategies including two elements appear to be helpful in preventing fluid
KEY POINTS
Fluid overload is associated with increased morbidity and mortality in critically ill patients.
Aggressive fluid resuscitation increases the risk of excessive fluid administration and fluid overload.
Fluid responsiveness should be assessed prior to fluid administration to reduce the risk of excessive fluid administration.
Fluid resuscitation strategies should include clear limits and individualized end-points to reduce the risk of excessive fluid administration.
Interventions aimed at achieving a negative fluid balance should be considered after adequately resuscitating patients with shock. ]. There was clinical evidence of fluid overload 24 h after admission in 67% of patients, and this persisted until day 3 of admission in 48% of patients. Patients with fluid overload on days 1 and 3 had a higher risk of hospital mortality compared with patients without fluid overload, highlighting the possible dangers of over-resuscitation with intravenous fluids. Second, removal of excess fluids should be promoted in patients whose shock has resolved. In patients with septic shock who have been adequately resuscitated, conservative fluid management leading to negative fluid balances is associated with a decrease in hospital mortality [4] .
These principles can be applied during the resuscitation of patients with shock which can be viewed as occurring in four phases corresponding to the acronym 'ROSE': resuscitation, optimization, stabilization and evacuation [12 & ]. The goals of fluid administration as well as the associated risk and benefits will vary depending on phase of resuscitation ( Fig. 1 ). The primary goal of fluid administration during the resuscitation phase is to rapidly correct systemic hypotension. During the optimization phase, the goal of fluid administration is to improve oxygen delivery to the tissues. In the stabilization phase, patients are hemodynamically stable and fluid administration should be restricted. In the evacuation phase, interventions are targeted at fluid removal.
RESUSCITATION PHASE
This is the initial phase of resuscitation in patients with severe systemic hypotension and evidence of tissue hypoperfusion, such as an elevated serum lactate. In this phase, the immediate goal is to correct the hypotension, and intravenous fluids are typically first-line therapy [13] . The volume of fluid required during this phase must be individualized and will necessarily vary between patients and according to fluid type. In sepsis-induced hypotension, the Surviving Sepsis Campaign guidelines recommend an initial minimum crystalloid fluid bolus of 30 ml/kg of body weight [13] . Multiple fluid boluses are often given to achieve a predefined BP target and frequently with limited hemodynamic monitoring such as routine bedside vital signs. Fluids should be given quickly as earlier resuscitation is associated with better outcomes. This was recently demonstrated in a study of 594 with severe sepsis and septic shock that examined the proportion of total fluids received during the first 3 h compared with the later 3 h and found that a higher proportion of total fluids received within the first 3 h of resuscitation was associated with improved survival [14 & ]. The BP targets will depend on the patient's underlying diagnosis. The recommended mean arterial pressure in the majority of patients with septic shock is 65 mmHg. This recommendation is supported by a recent randomized controlled trial that compared the effect of a high mean arterial pressure target (80À85 mmHg) with a low mean arterial pressure target (65À70 mmHg) in patients with septic shock [15 & ]. There were no significant differences in 28-day or 90-day mortality between both groups. However, patients with chronic hypertension in the group targeting a higher mean arterial pressure required less renal-replacement therapy than those in the group targeting a mean arterial pressure between 65 and 70 mmHg. This suggests that BP targets must be individualized, as a higher mean arterial pressure may confer benefit to specific populations of critically ill patients with shock.
Although the initial focus of resuscitation should be on fluid administration, vasopressor support should not be delayed in those with persistent hypotension. There is no consensus on the optimal timing of vasopressor use during this phase. However, the administration of vasopressors prior to adequate fluid resuscitation in hypovolemic patients can worsen organ perfusion and function. A retrospective study of 2849 patients with septic shock that examined the influence of the timing of fluid and vasopressor therapy as well as the total volume of fluids given on hospital mortality suggested that starting vasopressors within the first hour of resuscitation may be harmful [16 & ]. Conversely, delayed initiation of vasopressors in patients with persistent hypoperfusion despite fluid administration can also worsen end-organ damage and is associated with increased mortality [17
Ongoing or unmonitored volume resuscitation in patients with persistent hypotension increases the likelihood of excessive fluid administration. A reasonable approach for patients whose hypotension has not resolved after receiving a volume of crystalloid fluid equivalent to 30 ml/kg of body weight is to start a vasopressor while continuing fluid therapy guided with the aid of hemodynamic monitoring.
Optimization phase
The primary problem during the optimization phase of resuscitation is ongoing or occult tissue hypoperfusion. In this phase, the goal of fluid administration is to increase oxygen delivery to the tissues in order to meet cellular oxygen demands. Oxygen delivery (DO 2 ) is primarily a function of cardiac output (heart rate Â stroke volume), hemoglobin concentration and arterial oxygen saturation. The purpose of administering a fluid challenge is to increase oxygen delivery by increasing stroke volume and thus, cardiac output. Not all critically ill patients will respond in this manner to fluid bolus therapy (that is an increase in cardiac output, known as a fluid 'responder'). It is estimated, however, that 50% of patients are not fluid responders ('nonresponders') and will not increase stroke volume in response to a fluid challenge [19] . Further fluid challenges in such patients potentially expose them only to the harmful effects of fluid accumulation without providing any of the potential benefits. Consequently, fluid therapy aimed at improving oxygen delivery should be avoided in patients who are fluid nonresponders and a greater emphasis put on the use of vasoactive agents.
There is no gold standard for determining fluid responsiveness, but there is growing consensus . The passive leg raise technique in combination with measurement of cardiac output, stroke volume or aortic blood flow is effective in spontaneously breathing patients [29, 30] . In practice, the use of these techniques varies widely. A prospective multicenter study of adult patients with shock in 19 French ICUs showed significant between-center differences in the use of hemodynamic monitoring to guide fluid administration along with differences in both the total volume of fluids given during the first 4 days and the average size of individual fluid boluses [31 & ].
During the resuscitative phase, fluids must be administered in a timely and targeted manner with appropriate limits to fluid administration. Surrogate marker of tissue perfusion, such as serum lactate and ScvO 2 , is often used to determine the end-point of resuscitation. Three recent large multicenter randomized controlled studies in sepsis showed no benefit in using protocols that required continuous 
Stabilization phase
Patients in the stabilization phase of resuscitation have adequate tissue perfusion and may still require hemodynamic support with vasopressors, although the doses of these medications will be stable or decreasing. In this group, careful weighing of the potential risks and benefits of further fluid administration is required and further fluid administration should be restricted in patients without ongoing losses. In patients who are fluid responsive, a fluid challenge may be reasonable with the goal of decreasing vasopressor requirements. This must be balanced against the evidence that late goal-directed therapy may be associated with worse outcomes [35] .
Fluids should be restricted in patients not requiring hemodynamic support. In the absence of evidence suggesting hypoperfusion, fluid challenges should not be given, even in those who are fluid responsive. Careful attention must be paid to assess hypoperfusion, whether physiologically or with clinical laboratory tests. Maintenance fluids are usually not required and should be discontinued when possible as critically ill patients frequently receive sufficient fluids with medications and nutrition to account for insensible losses.
Evacuation phase
In this phase, the goal is to remove excess fluids in patients who are hemodynamically stable and do not have evidence of tissue hypoperfusion. Recent studies have demonstrated that protocols aimed at achieving a negative fluid balance are feasible and are associated with decreased morbidity. The Fluid and Catheter Treatment Trial (FACTT trial) enrolled 1000 patients with ARDS who were managed with either a conservative or liberal fluid strategy [36] . Patients with a mean arterial pressure more than 60 mmHg, no vasopressor support for more than 12 h, adequate urine output and circulation were either given furosemide targeted to achieve a CVP less than 4 mmHg or pulmonary artery occlusion pressure (PAOP) less than 8 mmHg (fluid conservative group) or CVP (< 10 mmHg) and PAOP (< 14 mmHg) (fluid liberal group). In this study, there was no difference in mortality but the conservative fluid strategy led to a more negative fluid balance at 7 days, 2.5 more days alive and free of mechanical ventilation and a shorter ICU length of stay.
In order to more easily operationalize a fluid restrictive strategy, a simplified version of the FACTT fluid management protocol was evaluated in a recent study [37 & ]. Using the 'FACTT lite' protocol, patients with MAP more than 60 mmHg and who were off vasopressors for more than 12 h were given furosemide to target a CVP less than 4 mmHg or PAOP less than 8 mmHg if they had adequate urine output [37 & ]. A total of 1124 patients who were managed with the FACTT lite protocol were retrospectively compared with the 497 patients managed with the FACTT liberal fluid strategy and the 503 patients who were managed with the FACTT conservative fluid strategy. The investigators found that management with the FACTT lite protocol resulted in a significantly lower fluid balance than the FACTT liberal protocol and no difference in the number of ventilator-free days compared with the FACTT conservative protocol. It appears that this simplified version of a fluid conservative approach achieves similar fluid balance, and we believe it would result in similar improved outcomes if compared with a historical liberal approach to fluid management.
Biomarkers may also be used to guide fluid removal in critically ill patients. In the B-type Natriuretic Peptide for the Fluid Management of Weaning (BMW) study, 304 mechanically ventilated patients were randomized to a B-type natriuretic peptide (BNP)-driven fluid management strategy or usual care [38, 39] . Patients in the BNPdriven group received diuretics and had fluid restricted on days when their BNP was at least 200 pg/ml. Duration of weaning was significantly shorter in the BNP-driven group, and there was a decreased incidence of ventilator-associated pneumonia and ventilator-associated events.
There is no consensus about the optimal timing of fluid removal, and there are limited data to guide a specific recommendation. In both the FACCT trial and the BMW trial, patients were required to have been off vasopressor therapy for at least 12 h before How to avoid fluid overload Ogbu et al.
diuretics were administered. A reasonable approach is to begin restricting fluids when patients achieve hemodynamic stability and/or normal tissue perfusion, and to consider initiating diuresis in patients who are hemodynamically stable with clinical evidence of fluid overload and unable to achieve a negative fluid balance spontaneously. An expert discussion of the pharmacologic management of fluid overload and the indications and management of mechanical fluid removal in critically ill patients was recently published [40 & ,41 & ]. There are understandable concerns about the risk of organ hypoperfusion associated with fluid removal. The data in this regard are inconclusive. The development of shock in patients managed with the FACTT lite protocol was not significantly different compared with patients managed with the FACTT liberal protocol [37 & ]. There are conflicting results regarding organ dysfunction with conservative fluid management in ARDS: greater cardiovascular dysfunction, and less acute neurological dysfunction [36] , although a subsequent report found a higher incidence of long-term cognitive dysfunction with conservative fluid therapy [42] . In the BMW trial, there was no difference in the incidence of renal failure between the intervention and control groups [38] . The impact of fluid conservative strategies on organ function requires additional study, particularly as it relates to the ebb and flow of fluid therapy in sepsis. Given these concerns, fluid removal should be performed cautiously with clear limits and appropriate safety monitoring to avoid inducing hypovolemia.
CONCLUSION
Fluid overload in the critically ill is a potentially preventable complication that is associated with increased morbidity and mortality. Specific fluid management strategies can be implemented during each phase of resuscitation to help mitigate the effects of fluid overload and thus, improve outcomes. Ultimately, the most effective fluid management strategy is the one that is individualized and emphasizes adequate early resuscitation and a more restrictive approach to fluid administration in the latter phases. Further research on how best to personalize fluid therapy in the critically ill is needed, particularly in the dynamic critically ill patient. A randomized controlled trial that compared early goal-directed therapy, protocolbased standard therapy and usual care in 1341 patients with septic shock. 33.
